ARE stock forecast: what analysts expect
Wall Street analysts covering Alexandria Real Estate Equities currently rate the stock a Hold on average, with a mean 12-month price target of $52.36 — +8.9% versus the last price of $48.06. Targets reflect analyst opinion, not a guarantee.
ARE historical returns
Based on monthly dividend-adjusted prices. See the full breakdown on what if you had invested in ARE.
ARE annual returns by year
Congress trading in ARE
4 members of Congress have disclosed trading ARE — 3 purchases and 2 sales worth an estimated $64,500. Most recent disclosure: Apr 14, 2026.
Insider activity in ARE
ARE's own executives and directors have made 0 open-market purchases ($0) and 1 sale ($108,000) in the last 90 days, per SEC Form 4 filings. Most recent: Jun 9, 2026.
| Jun 9, 2026 | Binda Marc E | CFO & Treasurer | Sell | $108,000 |
About Alexandria Real Estate Equities
Alexandria Real Estate Equities, Inc., an S&P 500 registered company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. With our founding in 1994, Alexandria pioneered the life science real estate niche. Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative Megacampus ecosystems in AAA life science and advanced technology innovation cluster locations, including Greater Boston, San Diego, the San Francisco Bay Area, Seattle, Maryland, Research Triangle, and New York City. As of June 30, 2026, Alexandria has a total market capitalization of 21.84 billion dollar and an asset base that includes 36.0 million RSF of operating properties and 2.8 million RSF of Class A/A+ properties undergoing construction. Alexandria has a long-standing and proven track record of developing Class A/A+ properties clustered in highly dynamic and collaborative Megacampus environments that enhance our tenants' ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value. Alexandria Real Estate Equities, Inc. was established in 1994 and incorporated in Maryland.
ARE Key Statistics
ARE in plain English
- ROE (-4.08%) — how efficiently the company turns shareholders' money into profit. Negative means it's currently losing money on that equity.
- Profit margin (-36.08%) — of every $1 in sales, this is what's left as profit after all costs.
- Dividend yield (5.99%) — the cash payout you'd earn per year as a % of the share price, on top of any price gains.
ARE stock: frequently asked questions
What is Alexandria Real Estate Equities's stock price today?
Alexandria Real Estate Equities (ARE) last traded at $48.06 on the NYSE. Over the past 52 weeks the stock has traded between $39.41 and $88.24.
Is ARE stock a buy or a sell?
Wall Street analysts' consensus rating on ARE is "Hold", with an average 12-month price target of $52.36 — about +8.9% versus the current price of $48.06. Analyst targets are opinions, not guarantees; always do your own research.
How much would $1,000 invested in ARE 10 years ago be worth today?
A $1,000 investment in Alexandria Real Estate Equities made 10 years ago would be worth about $628 today (dividends reinvested) — a total return of -37%, or -4.6% per year.
Does ARE pay a dividend?
Yes. Alexandria Real Estate Equities currently pays a dividend yielding about 5.99% per year at today's share price.
Do members of Congress trade ARE stock?
Yes — 4 members of Congress have disclosed trades in ARE under the STOCK Act, totaling 3 purchases and 2 sales worth an estimated $64,500.
What is Alexandria Real Estate Equities's ticker symbol?
Alexandria Real Estate Equities trades under the ticker symbol ARE on the NYSE.
Compare ARE with peers
Data last refreshed from public sources. Figures may be delayed. Not investment advice.